Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of ₹1,387.48 crore for the quarter ended June 30, 2019.
The company had posted a profit of ₹1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE.
Total revenue from operations for the quarter under review stood at ₹8,374.36 crore. It was ₹7,224.17 crore for the same period a year ago.
“Pola Pharma lnc Japan became a step-down subsidiary of the company with effect from January 1, 20l9. Accordingly, the results for the quarter include results of Pola Pharma Inc, and hence are not comparable with quarter ended June 30, 2018,” the company said.
Shares of Sun Pharmaceutical Industries were trading at ₹441 per scrip on BSE, up 4.53 per cent from the precious close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.